Setting the threshold to target HER2 positive breast cancer using chimeric antigen receptor engineered T-cells

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/201430/09/2017

Funding

  • Breast Cancer Campaign: £94,019.00